Olema Pharmaceuticals, Inc. (OLMA)
10.27
-0.52
(-4.82%)
USD |
NASDAQ |
Aug 28, 16:00
10.27
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Market Cap : 898.13M for Aug. 28, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 28, 2026 | 898.13M |
| August 27, 2026 | 943.61M |
| August 26, 2026 | 948.86M |
| August 25, 2026 | 954.10M |
| August 24, 2026 | 912.13M |
| August 21, 2026 | 934.86M |
| August 20, 2026 | 953.23M |
| August 19, 2026 | 989.08M |
| August 18, 2026 | 931.37M |
| August 17, 2026 | 941.86M |
| August 14, 2026 | 929.62M |
| August 13, 2026 | 919.12M |
| August 12, 2026 | 913.00M |
| August 11, 2026 | 912.13M |
| August 10, 2026 | 1.044B |
| August 07, 2026 | 1.054B |
| August 06, 2026 | 1.032B |
| August 05, 2026 | 1.011B |
| August 04, 2026 | 1.027B |
| August 03, 2026 | 985.12M |
| July 31, 2026 | 999.96M |
| July 30, 2026 | 1.032B |
| July 29, 2026 | 977.26M |
| July 28, 2026 | 1.015B |
| July 27, 2026 | 1.049B |
| Date | Value |
|---|---|
| July 24, 2026 | 1.022B |
| July 23, 2026 | 1.025B |
| July 22, 2026 | 1.003B |
| July 21, 2026 | 1.012B |
| July 20, 2026 | 991.23M |
| July 17, 2026 | 1.002B |
| July 16, 2026 | 966.78M |
| July 15, 2026 | 1.032B |
| July 14, 2026 | 1.035B |
| July 13, 2026 | 1.035B |
| July 10, 2026 | 1.040B |
| July 09, 2026 | 1.072B |
| July 08, 2026 | 1.072B |
| July 07, 2026 | 1.103B |
| July 06, 2026 | 1.115B |
| July 02, 2026 | 1.104B |
| July 01, 2026 | 1.055B |
| June 30, 2026 | 1.093B |
| June 29, 2026 | 1.065B |
| June 26, 2026 | 994.72M |
| June 25, 2026 | 998.22M |
| June 24, 2026 | 972.89M |
| June 23, 2026 | 919.62M |
| June 22, 2026 | 873.33M |
| June 18, 2026 | 830.54M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 5.011B |
| Alnylam Pharmaceuticals, Inc. | 31.71B |
| Anika Therapeutics, Inc. | 282.38M |
| Savara, Inc. | 1.080B |
| Vericel Corp. | 2.095B |
Market Cap Related Metrics
| PEG Ratio | -0.4774 |
| Price to Book Value | 2.086 |
| Price | 10.27 |
| Earnings Yield | -20.63% |
| PEGY Ratio | -0.4774 |